期刊文献+

小檗碱对神经元保护作用机制的研究进展 被引量:7

Research progress on action mechanism of the protective effect of berberine on neurons
原文传递
导出
摘要 小檗碱是一种异喹啉生物碱,具有多种药理作用。研究表明小檗碱可以通过影响多种途径发挥神经保护作用,包括PI3K/Akt/Bcl-2、Akt/Nrf-2/HO-1、GSK-3、MAPK、AMPK、阿尔茨海默病-β-淀粉样蛋白、NMDA受体和MMP-9途径。总结小檗碱在脑缺血、阿尔茨海默病和实验性自身免疫性脑脊髓炎等神经元疾病模型中的作用机制,了解更多关于小檗碱如何介导这些途径,为未来对神经疾病的临床治疗提供参考。 Berberin is an isoquinoline alkaloid with various pharmacologic effects. Recent research has demonstrated that berberine has neuroprotective effect through various pharmacological mechanisms, including PI3 K/Akt/Bcl-2, Akt/Nrf-2/HO-1, GSK-3, MAPK, AMPK, Alzheimer's disease-β-amyloid protein, NMDA receptor, and MMP-9. Thus, the action mechanism that plays roles in brain ischemia, Alzheimer's disease, experimental autoimmune encephalomyelitis etc. neuronal disease models is concluded in this review. Understanding more about how berberine mediates these pathways to provide reference for the clinical treatment of neurological disorders in the future.
作者 蔡悦 袁捷 刘晓龙 陈晓洁 CAI Yue;YUAN Jie;LIU Xiao-long;CHEN Xiao-jie(Department of Rheumatology,First Teaching Hospital of Tianjin University of TCM,Tianjin 300000,China;Department of Endocrinology,Tianjin Fifth Central Hospital,Tianjin 300450,China;Tianjin First Central Hospital,Tianjin 300192,China;Tianjin Municipal Commission of Health and Family Planning,Tianjin 300000,China)
出处 《现代药物与临床》 CAS 2018年第8期2154-2158,共5页 Drugs & Clinic
关键词 小檗碱 神经元保护 作用机制 berberine neuroprotection action mechanism
  • 相关文献

参考文献1

二级参考文献20

  • 1吴林根,陈敏.黄连素伍用谷维素对血脂和体重的影响[J].临床心血管病杂志,2007,23(8):576-578. 被引量:15
  • 2Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterollowering drug working through a unique mechanism distinct from statins [J]. Nat Med, 2004, 10(12): 1344- 1351.
  • 3Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natura! p|ant alkaloid berberine [J]. J Clin Endocrinol Metab, 2008, 93(7): 2559- 2565.
  • 4Liu Y, Hao H, Xie H, et al. Oxidative demethylenation and subsequent glucuronidation are the major metabolic pathways of berberine in rats [J]. J Pharm Sci, 2009, 98(11): 4391-4401.
  • 5Hua W, Ding L, Chert Y, et al. Determination of berberine in human plasma by liquid chromatography-electrospray ionization-mass spectrometry [J]. J Pharm Biomed Anal, 2007, 44(4): 931-937.
  • 6Han J, Lin H, Huang W. Modulation gut microbiota as an anti-diabetic mechanism of berberine [J]. Med Sei Monit, 2011, 17(7): 164-167.
  • 7Zhang X, Zhao Y, Zhang M, et al. Structural changes of gut microbiota during Berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats [J]. PLoS one, 2012, 7(8): e42529.
  • 8Ley R E, Turnbaugh P J, Klein S, et al. Microbial ecology: human gut microbes associated with obesity [J]. Nature, 2006, 444(7122): 1022-1023.
  • 9Xie W, Gu D, Li J, et al. Effects and action mechanisms of berberine and Rhizoma coptid is on gut microbes and obesity in high-fat-diet-fed C57BL/6J mice [J]. PLoS One, 2011, 6(9): e24520.
  • 10Aronsson L, Huang Y, Parini P, et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4) [J]. PLoS One, 2010, 5(9): e13087.

共引文献18

同被引文献177

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部